These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 28280138)
1. Sickle Cell Trait and the Risk of ESRD in Blacks. Naik RP; Irvin MR; Judd S; Gutiérrez OM; Zakai NA; Derebail VK; Peralta C; Lewis MR; Zhi D; Arnett D; McClellan W; Wilson JG; Reiner AP; Kopp JB; Winkler CA; Cushman M J Am Soc Nephrol; 2017 Jul; 28(7):2180-2187. PubMed ID: 28280138 [TBL] [Abstract][Full Text] [Related]
2. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968 [TBL] [Abstract][Full Text] [Related]
3. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals. Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855 [TBL] [Abstract][Full Text] [Related]
4. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study. Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582 [TBL] [Abstract][Full Text] [Related]
5. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087 [TBL] [Abstract][Full Text] [Related]
6. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study. Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069 [TBL] [Abstract][Full Text] [Related]
7. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial. Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095 [TBL] [Abstract][Full Text] [Related]
8. Race, APOL1 Risk, and eGFR Decline in the General Population. Grams ME; Rebholz CM; Chen Y; Rawlings AM; Estrella MM; Selvin E; Appel LJ; Tin A; Coresh J J Am Soc Nephrol; 2016 Sep; 27(9):2842-50. PubMed ID: 26966015 [TBL] [Abstract][Full Text] [Related]
9. APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline. Peralta CA; Bibbins-Domingo K; Vittinghoff E; Lin F; Fornage M; Kopp JB; Winkler CA J Am Soc Nephrol; 2016 Mar; 27(3):887-93. PubMed ID: 26180129 [TBL] [Abstract][Full Text] [Related]
10. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP; Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811 [TBL] [Abstract][Full Text] [Related]